News & Updates
Inside Innovation
The latest news and advances from the world's most exciting life science cluster.
BMS Commits up to $11B+ To Work With BioNTech on Solid Tumor Bispecific
Bristol Myers Squibb has entered into a partnership with BioNTech, committing up to $11.1 billion to co-develop and commercialize BNT327, a bispecific antibody targeting solid
Advanced colon cancer patients lived twice as long with a Pfizer combo therapy, trial finds
A combination drug treatment that includes Pfizer’s Braftovi has doubled survival time for some patients with advanced colorectal cancer, according to recently released late-stage trial
New learning lab opens the door to careers in science
With support and partnership from Alexandria Real Estate Equities, Fred Hutch unveiled a state-of-the-art learning lab where high school and college students can learn and
Allen Institute opens Education Lab to support and inspire next generation of scientists in Seattle and beyond
The Allen Institute has opened a new 1,327 square-foot Education Lab, providing immersive, authentic learning experiences for learners at all levels. “Our unique lab experiences
Researchers develop a new set of genetic tools designed to treat brain diseases
A consortium of researchers, including those from Seattle’s Allen Institute for Brain Science and the University of Washington, created a new molecular toolkit with potential
Seattle’s Allen Institute launches ‘moonshot’ to create new approach to cell biology research
Seattle’s Allen Institute launched a bold new initiative, CellScapes, which uses AI and mathematics to create a novel framework for understanding cellular biology. With 75
Seattle-area company VerAvanti lands $31.5M to develop scopes to prevent strokes, heart attacks
Bothell-based VerAvanti announced it has raised $31.5 million to further develop its ultra-thin imaging scopes aimed at preventing strokes and heart attacks. Founded on technology
FDA gives AI-powered blood test for obstructive CAD breakthrough device designation
Kirkland-based Prevencio has earned FDA breakthrough device designation for its HART CADhs test, an AI-powered, multi-protein blood test for detecting obstructive coronary artery disease. HART
A Day in the Life of a Pfizer Oncology Strategy Leader
Tolani Osho is driven by a powerful challenge each day: what more can we do, together with our partners, to change the future of how
Proprio receives second FDA clearance for AI platform that captures key data during surgery
Seattle-based Proprio, a startup using artificial intelligence to improve surgical precision, announced its second major clearance from the U.S. Food and Drug Administration to include
Bristol Myers to invest $40 billion in the US over 5 years
Bristol Myers Squibb recently announced it will invest $40 billion in the U.S. over the next five years to expand its research and manufacturing presence.
AGC Biologics & Novelty Nobility Partner for Cell Line Development
Headquartered in Seattle, AGC Biologics has entered a multiphase partnership with Novelty Nobility Inc., a clinical-stage biotech company based in South Korea. As part of